Format

Send to

Choose Destination
Antonie Van Leeuwenhoek. 2005 May;87(4):277-81.

Tularemia vaccine: past, present and future.

Author information

1
Defence Science and Technology Laboratories, Porton Down, Salisbury, Wiltshire, SP4 0JQ. pcoyston@dstl.gov.uk

Abstract

Francisella tularensis is a Gram negative intracellular pathogen that causes the highly debilitating or fatal disease tularemia. F. tularensis can infect a wide range of animals and can be transmitted to humans in a variety of ways, the most common being by the bite of an infected insect or arthropod vector. The attenuated F. tularensis live vaccine strain (LVS) has been used previously under investigational new drug status to vaccinate at-risk individuals. However the history of the strain and lack of knowledge regarding the basis of attenuation has so far prevented its licensing. Therefore the focus of current research is on producing a new vaccine against tularemia that would be suitable for licensing.

PMID:
15928980
DOI:
10.1007/s10482-004-6251-7
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center